Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Canada
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Weekly News Recap #Phispers
Global Sales Information
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2020 Revenue in Millions : 306
2019 Revenue in Millions : 166
Growth (%) : 84
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2021 Revenue in Millions : 475
2020 Revenue in Millions : 306
Growth (%) : 55
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2022 Revenue in Millions : 558
2021 Revenue in Millions : 475
Growth (%) : 17
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2023 Revenue in Millions : 355
2022 Revenue in Millions : 558
Growth (%) : -36
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?